Serum interleukin-17 levels are related to clinical severity in allergic rhinitis.
cross_sectional · Level IV
Where this comes from
- Record sourced from PubMed, PMID 19226302.
- Also identified by DOI 10.1111/j.1398-9995.2009.02010.x.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
T helper (Th)-17 cells are a subset of T helper lymphocytes that exert regulatory activities. Recently, it has been reported that serum interleukin (IL)-17 levels are high in the most severe cases of birch allergy studied outside the pollen season. The aim of this study was to investigate a possible relationship between serum IL-17 levels and clinical parameters in patients with allergic rhinitis studied during the pollen season. In all, 56 patients with persistent pollen-induced allergic rhinitis were evaluated during the pollen season. Serum IL-17 levels were evaluated by enzyme-linked immunosorbent assay. Symptoms were assessed by visual analogue scale, drug use was monitored and peripheral eosinophils were counted. Serum IL-17 levels were significantly related to clinical symptoms, drug use and peripheral eosinophil counts (P = 0.0001 for all). This study provides evidence that serum IL-17 level assessment might be considered to classify allergy severity.
Medical subject headings
- Interleukin-17
- Rhinitis, Allergic, Seasonal
- Severity of Illness Index
- T-Lymphocytes, Helper-Inducer